Bruker
产品与解决方案 应用 服务与支持 新闻和活动 关于我们 职业
请至少输入2个字符 (您当前输入的是1个字符) 。

Languages

ASBMB
Mass Spectrometry in the Health and Life Sciences

August 14 - 18, Cambridge, MA, USA

Workshop

Monday, August 15, 12:30 pm - 2:00 pm

Location: Auditorium, Broad Institute of MIT and Harvard

Lunch will be served

Talk 1: Robust and streamlined clinical proteomics with the Evosep and Bruker platforms
Speaker: Prof. Matthias Mann, Ph.D.

Talk 2: Unraveling multi-level tissue heterogeneity at single-cell and low input using the timsTOF SCP
Speaker: Claudia Ctorecka, Ph.D.

Speakers

Prof. Matthias Mann, Ph.D., Director, Department of Proteomics and Signal Transduction, Max-Planck-Institute of Biochemistry, Martinsried, Germany

Prof. Matthias Mann is head of the department of Proteomics and Signal Transduction which was established in 2005. Matthias Mann is the highest cited German researcher by his h-index of more than 245 and over 290,000 citations. In addition to his group at the Max Planck Institute of Biochemistry, Matthias Mann is the director of the proteomics program at the Novo Nordisk Foundation Center for Protein Research (NNF-CPR) in Copenhagen where he also leads the Clinical Proteomics group. The Mann lab is a leader in the technology and application of mass spectrometry-based proteomics and has been at the forefront of the field for over two decades. The core research interests of the group are signal transduction, biomarker discovery and metabolic diseases. Another focus is the development of mass spectrometric and proteomic methods for application in biological and clinical contexts. The group is also developing computer algorithms for automated identification and quantification of peptides as well as systems biological and clinical knowledge mining. Ultimately, our vision is to transfer proteomics knowledge into clinics for predictive, diagnostic and preventive purposes.

Claudia Ctorecka, Ph.D., Postdoctoral Fellow, Carr Laboratory, Broad Institute of MIT and Harvard, Cambridge, MA, USA

Claudia is a PostDoc in Steve Carr’s group at the Broad institute of MIT and Harvard since the beginning of the year, where she will be working on low input and single cell proteomics workflows. Prior to that she conducted her PhD research at the Research Institute of Molecular Pathology (IMP) in Vienna with Karl Mechtler. In collaboration with Cellenion using their picoliter dispensing robot, the cellenONE®, she co-developed a complete solution for multiplexed single-cell sample preparation, the proteoCHIP.

 

For Research Use Only. Not for use in clinical diagnostic procedures.